Vitiligo Clinical Trials in Indiana

Take the next step towards participating in a vitiligo clinical trial by completing this form.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Seeking Better Options for Potential Vitiligo Treatment?

Vitiligo is an autoimmune disease that causes the immune system to destroy pigment-producing skin cells, leading to white patches on the skin. In the U.S., vitiligo affects about 1% of the population, causing significant cosmetic and emotional distress. Current vitiligo clinical trials in Indiana are exploring potential vitiligo treatments, including a potential new drug for non-segmental vitiligo (NSV). Participants will either receive the study drug or a placebo for 48 weeks (about 11 months) and then continue with the study drug for an additional 112 weeks (about 2 years).

Besides this primary trial, additional studies are investigating other non-segmental Vitiligo treatment options. A second Vitiligo investigational drug is being tested for its effectiveness, while a third trial evaluates another new medication. Throughout these research studies, participants will take either her investigational medicine or a placebo and undergo extensive monitoring over 26 months (about 2 years). This involves regular visits and various medical tests to thoroughly assess the treatment’s safety and impact, offering hope for improved management of vitiligo.

*Participating in the Clinical Trial is entirely free, and the decision to join is yours.
To take part, fill out the form, and a research team member will contact you to assess your eligibility for this atopic dermatitis clinical trial.*

Non-Segmental Vitiligo

Non-segmental vitiligo is a condition where the immune system attacks pigment-producing cells, causing white patches to appear symmetrically on both sides of the body. These patches often appear on the face, hands, and other exposed areas. Join us in exploring new treatments through vitiligo clinical studies and help bring color back into the lives of those affected.

Non-Segmental Vitiligo Representation

Non-segmental vitiligo manifests as symmetrical white patches on sun-exposed areas, along with premature graying of hair, loss of mucous membrane color, and potential changes in eye pigmentation.

Risk Factors of Vitiligo

Risk factors for vitiligo include family history, autoimmune diseases, such as thyroid disorders or diabetes, and triggers like stress or exposure to certain chemicals or environmental factors.

study

Vitiligo Clinical
Trials